Literature DB >> 10922466

Evidence that the substrate backbone conformation is critical to phosphorylation by p42 MAP kinase.

M Weiwad1, G Küllertz, M Schutkowski, G Fischer.   

Abstract

The effect of prolyl bond isomers on the substrate recognition capabilities of various endoproteases may be investigated in a reaction where both cis/trans isomers co-exist. Here we address the question of whether enzyme reactions at the side chain of an amino acid preceding proline proceed through an isomer specific pathway. The proline-directed p42 mitogen-activated protein kinase (ERK2) was used to phosphorylate the serine side chain in Pro-Arg-Ser-Pro-Phe-4-nitroanilide under conditions where different amounts of cis prolyl isomer of the substrate were present. Initial phosphorylation rates were calculated ranging between zero at 100% cis isomer and around 60 pM/min at the equilibrium content of 83.5% trans isomer. In the presence of the peptidyl-prolyl cis/trans isomerase human hFKBP12 (500 nM), cis/trans isomerization proceeds rapidly, permitting the maximal phosphorylation rate to be observed in the dead time of the experiment. Results show that correct signature sequences are not sufficient to render potential substrates reactive to proline-directed enzymatic phosphorylations, but that the conformational state of the peptide bond following serine (threonine) is a critical determinant. Therefore, catalysis by peptidyl-prolyl cis/trans isomerases may add a new level of control to intracellular protein phosphorylations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922466     DOI: 10.1016/s0014-5793(00)01794-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Peptidyl-prolyl isomerases: a new twist to transcription.

Authors:  Peter E Shaw
Journal:  EMBO Rep       Date:  2002-06       Impact factor: 8.807

2.  PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.

Authors:  Kwang Youl Lee; Jeong Woon Lee; Hyun Jeong Nam; Jeong-Hyun Shim; Youngsup Song; Keon Wook Kang
Journal:  Mol Cells       Date:  2011-05-11       Impact factor: 5.034

3.  A conserved pathway that controls c-Myc protein stability through opposing phosphorylation events occurs in yeast.

Authors:  Julienne R Escamilla-Powers; Rosalie C Sears
Journal:  J Biol Chem       Date:  2006-12-27       Impact factor: 5.157

4.  Proline and lysine residues provide modulatory switches in amyloid formation: Insights from prion protein.

Authors:  Allison Kraus
Journal:  Prion       Date:  2016       Impact factor: 3.931

5.  Cell signaling, post-translational protein modifications and NMR spectroscopy.

Authors:  Francois-Xavier Theillet; Caroline Smet-Nocca; Stamatios Liokatis; Rossukon Thongwichian; Jonas Kosten; Mi-Kyung Yoon; Richard W Kriwacki; Isabelle Landrieu; Guy Lippens; Philipp Selenko
Journal:  J Biomol NMR       Date:  2012-09-26       Impact factor: 2.835

Review 6.  Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?

Authors:  Martin Balastik; Jormay Lim; Lucia Pastorino; Kun Ping Lu
Journal:  Biochim Biophys Acta       Date:  2007-01-23

Review 7.  Dephosphorylating eukaryotic RNA polymerase II.

Authors:  Joshua E Mayfield; Nathaniel T Burkholder; Yan Jessie Zhang
Journal:  Biochim Biophys Acta       Date:  2016-01-15

8.  FKBP12 regulates the localization and processing of amyloid precursor protein in human cell lines.

Authors:  Fan-Lun Liu; Ting-Yi Liu; Fan-Lu Kung
Journal:  J Biosci       Date:  2014-03       Impact factor: 1.826

Review 9.  The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.

Authors:  Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Rev Cancer       Date:  2016-06-03       Impact factor: 60.716

Review 10.  Cross-talk of phosphorylation and prolyl isomerization of the C-terminal domain of RNA Polymerase II.

Authors:  S D Yogesha; Joshua E Mayfield; Yan Zhang
Journal:  Molecules       Date:  2014-01-27       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.